JPND – Large scale analysis of OMICS data for drug-target finding in neurodegenerative diseases – 2023

JPND - Large scale analysis of omics data for drug-target finding in neurodegenerative diseases aiming at establishing a number of ambitious, innovative, multi-disciplinary and multinational collaborative research projects

2023-03-07

16.5 million euro

Additional information

Additional regional information :

Eligible countries to the programme: Click here

Amount :

To view this information , thank you for logging in.

Useful :

To view this information , thank you for logging in.

Sectors : Health Research & Innovation

Beneficiary : Large company (> 250 employees) Research centre & university Smes & Start-Ups (< 249 Employees)

Regions : Developing countries, European Economic Area, European Union, Northern America

Category : Call for proposals

Manager : European Commission

Contact :

To view this information , thank you for logging in.

Priorities and funded actions

Objectives

To establish a number of ambitious, innovative, multi-disciplinary and multinational collaborative research projects that seek to improve the understanding of the complex and multifactorial pathogenesis of neurodegenerative diseases by applying multi-OMICs and Big data approaches in order to generate useful information for the diagnosis, treatment, prognosis, and drug discovery of neurodegenerative diseases

Priorities

Priority 1: Alzheimer’s disease and other dementias
Priority 2: Parkinson’s disease and PD-related disorders
Priority 3: Prion diseases
Priority 4: Motor neuron diseases
Priority 5: Huntington’s disease
Priority 6: Spinocerebellar ataxia (SCA)
Priority 7: Spinal muscular atrophy (SMA)

Among financed actions

Using the potential from existing animal and cellular models and cohorts, including available data and biomaterial, for conducting large-scale OMICS approaches to unravel the interplay and interactions of molecules from multiple molecular levels driving disease pathogenesis
Better understanding the complex and multi-factorial mechanisms of disease onset and progression as well as the corresponding influencing factors
Translating the findings from Big Data analysis and multi-OMICS approaches to existing animal and cellular models, thereby enhancing the potential of these models
Identification of new drug targets or novel starting points for pharmacological interventions and prevention
Sharpening the current understanding of disease definition, thus leading to enhanced subclassification and better patient stratification
Identification of novel and validation of already established biomarkers

Additional information

This call for proposals is an open call for proposals
Initial duration of the call: 3 years

Eligibility

Be a universities or other higher education institutions
Be a non-university public or private research organisations
Be an hospital and other health and social care settings
Be a commercial companies, in particular small and mediumsize enterprises (SMEs)
Be a companies from outside the traditional medical sector (e.g. computing, artificial intelligence)

Similar news

10 February 2023

Why work with a consultant for your European project?

Lire l'aticle

2 February 2023

How to identify European funds?

Lire l'aticle

JPND – Large scale analysis of OMICS data for drug-target finding in neurodegenerative diseases – 2023

Additional information

Priorities and funded actions

Eurofunding gathers more than 300 European grant programs updated and linked to weekly alerts on calls for projects. Subscribe for free and don't miss any more opportunities.

Similar news

Why work with a consultant for your European project?

How to identify European funds?